These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 27769033

  • 1. Urea-containing peptide boronic acids as potent proteasome inhibitors.
    Han LQ, Yuan X, Wu XY, Li RD, Xu B, Cheng Q, Liu ZM, Zhou TY, An HY, Wang X, Cheng TM, Ge ZM, Cui JR, Li RT.
    Eur J Med Chem; 2017 Jan 05; 125():925-939. PubMed ID: 27769033
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors.
    Ge Y, Li A, Wu J, Feng H, Wang L, Liu H, Xu Y, Xu Q, Zhao L, Li Y.
    Eur J Med Chem; 2017 Mar 10; 128():180-191. PubMed ID: 28182990
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of novel selective peptidomimetics containing a boronic acid moiety, targeting the 20S proteasome as anticancer agents.
    Scarbaci K, Troiano V, Ettari R, Pinto A, Micale N, Di Giovanni C, Cerchia C, Schirmeister T, Novellino E, Lavecchia A, Zappalà M, Grasso S.
    ChemMedChem; 2014 Aug 10; 9(8):1801-16. PubMed ID: 24891205
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synthesis and biological activity of peptide proline-boronic acids as proteasome inhibitors.
    Han L, Wen Y, Li R, Xu B, Ge Z, Wang X, Cheng T, Cui J, Li R.
    Bioorg Med Chem; 2017 Aug 01; 25(15):4031-4044. PubMed ID: 28634039
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and biological evaluation of curcumin derivatives modified with α-amino boronic acid as proteasome inhibitors.
    Zhang W, Bai H, Han L, Zhang H, Xu B, Cui J, Wang X, Ge Z, Li R.
    Bioorg Med Chem Lett; 2018 Aug 01; 28(14):2459-2464. PubMed ID: 29886021
    [Abstract] [Full Text] [Related]

  • 8. Discovery of a novel dipeptidyl boronic acid proteasome inhibitor for the treatment of multiple myeloma and triple-negative breast cancer.
    Lei M, Feng H, Bai E, Zhou H, Wang J, Qin Y, Zhang H, Wang X, Liu Z, Hai O, Liu J, Zhu Y.
    Org Biomol Chem; 2019 Jan 16; 17(3):683-691. PubMed ID: 30601533
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Exploration of novel piperazine or piperidine constructed non-covalent peptidyl derivatives as proteasome inhibitors.
    Zhuang R, Gao L, Lv X, Xi J, Sheng L, Zhao Y, He R, Hu X, Shao Y, Pan X, Liu S, Huang W, Zhou Y, Li J, Zhang J.
    Eur J Med Chem; 2017 Jan 27; 126():1056-1070. PubMed ID: 28027531
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors.
    Troiano V, Scarbaci K, Ettari R, Micale N, Cerchia C, Pinto A, Schirmeister T, Novellino E, Grasso S, Lavecchia A, Zappalà M.
    Eur J Med Chem; 2014 Aug 18; 83():1-14. PubMed ID: 24946214
    [Abstract] [Full Text] [Related]

  • 13. Probing the specificity and activity profiles of the proteasome inhibitors bortezomib and delanzomib.
    Berkers CR, Leestemaker Y, Schuurman KG, Ruggeri B, Jones-Bolin S, Williams M, Ovaa H.
    Mol Pharm; 2012 May 07; 9(5):1126-35. PubMed ID: 22432738
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Structurally novel highly potent proteasome inhibitors created by the structure-based hybridization of nonpeptidic belactosin derivatives and peptide boronates.
    Kawamura S, Unno Y, Asai A, Arisawa M, Shuto S.
    J Med Chem; 2014 Mar 27; 57(6):2726-35. PubMed ID: 24524217
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Syringolin B-inspired proteasome inhibitor analogue TIR-203 exhibits enhanced biological activity in multiple myeloma and neuroblastoma.
    Opoku-Ansah J, Ibarra-Rivera TR, Pirrung MC, Bachmann AS.
    Pharm Biol; 2012 Jan 27; 50(1):25-9. PubMed ID: 22196580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.